| Literature DB >> 25450384 |
Bin Dai1, Zhiqiang Hu2, Hui Huang1, Guangtong Zhu1, Zhiyong Xiao1, Weiqing Wan3, Peng Zhang3, Wang Jia3, Liwei Zhang3.
Abstract
Epigenetic alterations such as aberrant expression of histone-modifying enzymes have been implicated in tumorigenesis. Upregulation of lysine (K)-specific demethylase 5B (KDM5B) has been reported in a variety of malignant tumors. However, the impact of KDM5B in glioma remains unclear. The objective of this study was to investigate the expression and prognostic value of KDM5B in glioma. In clinical glioma samples, we found that KDM5B expression was significantly upregulated in cancer lesions compared with normal brain tissues. Kaplan-Meier analysis showed that patients with glioma and higher KDM5B expression tend to have shorter overall survival time. By silencing or overexpressing KDM5B in glioma cells, we found that KDM5B could promote cell growth both in vitro and in vivo. Moreover, we demonstrated that KDM5B promoted glioma proliferation partly via regulation of the expression of p21. Our study provided evidence that KDM5B functions as a novel tumor oncogene in glioma and may be a potential therapeutic target for glioma management.Entities:
Keywords: Glioma; KDM5B; Proliferation
Mesh：
Substances：
Year: 2014 PMID： 25450384 DOI： 10.1016/j.bbrc.2014.10.078
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN： 0006-291X Impact factor: 3.575